According to CytomX Therapeutics 's latest financial reports the company's current revenue (TTM ) is โฌ31.24 Million. In 2025 the company made a revenue of โฌ64.86 Million a decrease over the revenue in the year 2024 that were of โฌ0.13 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.